| P50 | author | Adriano Martimbianco de Assis | Q48131104 |
| P2093 | author name string | Anderson Rech | |
| | Fábio Klamt | |
| | Leonardo Lisbôa da Motta | |
| | Diogo Onofre Souza | |
| | Carolina Guerini de Souza | |
| | Ricardo Bruch | |
| P2860 | cites work | Tissue sulfhydryl groups | Q26778486 |
| | Oxidative Stress and Diabetic Complications | Q29615423 |
| | Catalase in vitro | Q29615710 |
| | Pathophysiology of diabetes. A review of selected recent developments and their impact on treatment | Q35153950 |
| | Insulitis in human type 1 diabetes: The quest for an elusive lesion | Q35159105 |
| | Global health and primary care: increasing burden of chronic diseases and need for integrated training | Q35185034 |
| | Prevention of diabetic nephropathy by sulforaphane: possible role of Nrf2 upregulation and activation | Q36289400 |
| | Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus | Q37141727 |
| | Renal function in diabetic disease models: the tubular system in the pathophysiology of the diabetic kidney | Q37253944 |
| | Protective effect of sulforaphane against oxidative stress: recent advances | Q37815695 |
| | Diabetes mellitus and thrombosis | Q37971199 |
| | Combating oxidative stress in diabetic complications with Nrf2 activators: how much is too much? | Q38190096 |
| | Sulforaphane protects against cytokine- and streptozotocin-induced beta-cell damage by suppressing the NF-kappaB pathway | Q38497459 |
| | Prevention by sulforaphane of diabetic cardiomyopathy is associated with up-regulation of Nrf2 expression and transcription activation | Q39204026 |
| | Influence of rutin treatment on biochemical alterations in experimental diabetes | Q43237012 |
| | Sulforaphane attenuates obesity by inhibiting adipogenesis and activating the AMPK pathway in obese mice | Q43754986 |
| | Metabolic effects of sulforaphane oral treatment in streptozotocin-diabetic rats | Q47218576 |
| | Chronic sulforaphane oral treatment accentuates blood glucose impairment and may affect GLUT3 expression in the cerebral cortex and hypothalamus of rats fed with a highly palatable diet. | Q50881861 |
| | Diagnosis and Classification of Diabetes Mellitus | Q56001184 |
| P433 | issue | 4 | |
| P304 | page(s) | 2060-2065 | |
| P577 | publication date | 2016-04-01 | |
| P1433 | published in | Food & Function | Q3076426 |
| P1476 | title | Sulforaphane ameliorates the insulin responsiveness and the lipid profile but does not alter the antioxidant response in diabetic rats. | |
| P478 | volume | 7 | |